Scholarlink

<p>Healthcare workers (HCW) constitute a high-risk group to hepatitis B virus (HBV) infection, which can be curtailed by vaccination. Despite two decades of HBV vaccinations in Ghana, there is limited data on the sero-protection (anti-HBs titer ≥ 10 mIU/ml) rate among vaccinated individuals. To determine the extent of anti-HBs sero-protection among HCW, we conducted a cross-sectional study involving 150 HBV-vaccinated HCW at the Tamale Teaching Hospital, who were recruited between March and September 2019. Demographics and vaccination history were collected through questionnaires. Blood samples were tested for HBsAg and anti-HBs antibodies using test kits and ELISA immunoassay respectively. Results showed that 62% of HBV-vaccinated HCW had sufficient protection, with a mean titer of 338.6 ± 387.6 mIU/ml. However, 38% had antibody titers below the protective threshold (&lt; 10 mIU/ml). Notably, one individual with suboptimal immunity tested positive for HBsAg. Age, but not gender and body mass index, influenced the antibody levels. Our findings suggest that a substantial proportion of HBV-vaccinated HCW in Ghana may lack adequate seroprotection and may be prone to HBV infection. The study highlights the importance of considering routine evaluation of anti-HBs antibody titers among HCW to better inform occupational health policies.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Suboptimal immunity of hepatitis B vaccination and seroprotection among healthcare professionals in a tertiary hospital in Ghana

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月18日

查看全文
  • Benedict Boateng Antuamwine,
  • Obed Moafagma Kuchando,
  • Walida Alhassan,
  • Maxwell Akonde

摘要

Healthcare workers (HCW) constitute a high-risk group to hepatitis B virus (HBV) infection, which can be curtailed by vaccination. Despite two decades of HBV vaccinations in Ghana, there is limited data on the sero-protection (anti-HBs titer ≥ 10 mIU/ml) rate among vaccinated individuals. To determine the extent of anti-HBs sero-protection among HCW, we conducted a cross-sectional study involving 150 HBV-vaccinated HCW at the Tamale Teaching Hospital, who were recruited between March and September 2019. Demographics and vaccination history were collected through questionnaires. Blood samples were tested for HBsAg and anti-HBs antibodies using test kits and ELISA immunoassay respectively. Results showed that 62% of HBV-vaccinated HCW had sufficient protection, with a mean titer of 338.6 ± 387.6 mIU/ml. However, 38% had antibody titers below the protective threshold (< 10 mIU/ml). Notably, one individual with suboptimal immunity tested positive for HBsAg. Age, but not gender and body mass index, influenced the antibody levels. Our findings suggest that a substantial proportion of HBV-vaccinated HCW in Ghana may lack adequate seroprotection and may be prone to HBV infection. The study highlights the importance of considering routine evaluation of anti-HBs antibody titers among HCW to better inform occupational health policies.